SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dell Technologies, Inc. is a technology company, providing customers with a broad and innovative solution portfolio to help customers modernize their information technology (IT) infrastructure, address workforce transformation, and offer critical solutions that keep people and organizations connected. It operates through the following segments: Infrastructure Solutions Group (ISG) and Client Solutions Group (CSG). The ISG segment includes servers, networking, and storage, as well as services and third-party software and peripherals that are closely tied to the sale of ISG hardware. The CSG segment includes designs for commercial and consumer customers of desktops, thin client products, and notebooks. The company was founded by Michael Saul Dell in 1984 and is headquartered in Round Rock, TX.

Dell Technologies Inc - Ordinary Shares - Class C

Dell Technologies Inc

Dell Technologies is trending as traders focus on the company's upcoming quarterly earnings report, with sentiment divided between expectations of strong AI-server demand and concerns about broader tech sector weakness. The community is closely watching the company's commentary on backlog and margins, which is seen as a key read-through for the AI infrastructure market.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple shares are trending amid a leadership transition as John Ternus officially succeeds Tim Cook as CEO, while the company also faces news of a trade-secret lawsuit against OpenAI. Traders are closely watching these developments ahead of an upcoming product launch event, with sentiment split between optimism over the new leadership and skepticism regarding the stock's recent valuation.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is trending as traders react to heightened tensions in the Middle East, specifically reports of military strikes by U.S. forces against targets in the Strait of Hormuz. The community remains divided, with some traders debating potential supply disruptions and bullish price impacts, while others express skepticism over market manipulation and the sustainability of current oil price levels.

PG&E Corp. operates as a holding company, which engages in generation, transmission, and distribution of electricity and natural gas to customers. It specializes in energy, utility, power, gas, electricity, solar, and sustainability. The company was founded on November 17, 1995 and is headquartered in Oakland, CA.

PG&E Corp.

PCG is seeing heightened activity driven by a combination of institutional options speculation and uncertainty surrounding potential wildfire liability risks in California. While some investors are betting on a recovery supported by demand for grid infrastructure and data center energy, others remain cautious due to ongoing regulatory pressures and wildfire-related volatility.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

Traders are closely monitoring rising oil prices and bond yields, which were spurred by news of U.S. strikes against Iranian targets in the Strait of Hormuz. Despite initial selling, the community is debating whether this marks a sustainable market decline or if, as many traders argue, it is an opportunity to buy the dip following a pattern of market resilience.

Fervo Energy Co. operates as a energy company. It builds and operates power facilities in extracting geothermal energy. The company was founded by Jack Norbeck and Timothy Latimer in 2017 and is headquartered in Berkeley, CA.

Fervo Energy Co. - Ordinary Shares - Class A

Fervo Energy Co

Fervo Energy is trending following the announcement of a major power purchase agreement with Google to supply geothermal energy for potential data center development. While some traders view the deal as a significant fundamental de-risking event that validates the company's utility-scale commercial model, others remain skeptical, citing concerns over future dilution, lack of current profitability, and the long timeline before projects become operational.

Credo Technology Group Holding Ltd. engages in the development of connectivity solutions and products for the data infrastructure market. Its products include integrated circuits, active electrical cables, and SerDes chiplets. The company was founded by Chi Fung Cheng and Yat Tung Lam on 2008 and is headquartered in George Town, Cayman Islands.

Credo Technology Group Holding Ltd

Credo Technology is experiencing heightened volatility and selling pressure as traders react to broad market macro concerns and speculation regarding potential U.S. restrictions on Chinese optical transceiver components. While some investors remain cautious about customer concentration and sector-wide headwinds, many see the price drop as a buying opportunity, citing the company's strong fundamentals and growth potential within the AI data center infrastructure market.

Palo Alto Networks, Inc. engages in the provision of network security solutions to enterprises, service providers, and government entities. It operates through the following geographical segments: the United States, Israel, and Other Countries. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

Palo Alto Networks is trading lower as traders express concern over the company's valuation, high price-to-earnings multiples, and skepticism regarding its recent market rally. The conversation is fragmented, with some participants citing potential manipulation and profit-taking ahead of upcoming earnings, while others debate the long-term impact of AI on cybersecurity demand.

QXO, Inc. is a publicly traded distributor of roofing, waterproofing and complementary building products in the United States. It plans to become tech-enabled in the building products distribution industry and generate outsized value for shareholders. The company was founded on October 3, 2002, and is headquartered in Greenwich, CT.

QXO Inc.

QXO is trending as traders speculate on a potential price breakout ahead of earnings, with many anticipating a recovery toward historical highs despite ongoing concerns regarding macroeconomic pressures and short-selling activity. The sentiment remains divided, characterized by a mix of long-term conviction in the company’s business consolidation strategy and frustration over recent volatility and dilution.

CrowdStrike Holdings, Inc. provides cybersecurity products and services to stop breaches. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, Zero Trust identity protection, and log management. CrowdStrike serves customers worldwide. The company was founded by George P. Kurtz, Gregg Marston, and Dmitri Alperovitch on November 7, 2011 and is headquartered in Austin, TX.

Crowdstrike Holdings Inc - Ordinary Shares - Class A

Crowdstrike Holdings Inc

CrowdStrike shares declined following the company's financial report, with traders expressing concerns over the company's valuation metrics and the disconnect between GAAP and non-GAAP figures despite beating quarterly earnings estimates. While some community members highlight the positive long-term potential of the firm's AI-driven cybersecurity partnerships, many are focused on the stock's volatility and its premium valuation compared to industry peers.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SLS, IBRX Stocks Post August Gains: Eli Lilly’s Latest $2.9B Deal Has Retail Traders Bracing For An ‘M&A Rampage’

Equity

Retail traders viewed the Merida acquisition as evidence that Big Pharma will pay rich premiums for immune-focused platforms.

IBRX Stock Heads For Best Week In Over 2 Months After Chairman Soon Shiong’s Cancer Vaccine Trial Milestone Update

Patrick Soon-Shiong said the trial has been fully accrued and passed its one-year mark.

SLS, IBRX Eye Fresh Oncology Tailwind As Cathie Wood’s ARK Backs Personalized Cancer-Vaccine Future 

ARK sees a path toward custom cancer treatments for every patient, though current costs of $200,000-$300,000 remain a major hurdle.

SLS, IBRX Catch The Eye Of A Major US Pension Fund — And Big Clinical Catalysts Are On The Horizon

Virginia Retirement System disclosed SLS and IBRX stakes worth nearly $909,000 combined.

IBRX Stock Extends 3-Day Slide — Founder Teases New Trial In ‘Unstoppable’ Cancer-Treatment Push

Soon-Shiong teased a trial pairing Pluvicto’s targeted radiation with an IL-15-based immune treatment.

SLS, IBRX Stocks In Focus: Analyst Says Moderna-Merck Cancer Vaccine Success ‘Bodes Well’ For Oncology

Moderna soared 177% Wednesday, while Merck gained 13% and the rally spread to BioNTech, Arcturus, Tempus AI and Novavax.

Moderna Is Now S&P 500’s No. 2 Stock This Year — Wall Street, Jim Cramer And Elon Musk Cheer Cancer Vaccine Breakthrough

The breakthrough sparked a broad biotech rally, lifting Merck, BioNTech, Arcturus, cancer-treatment developers, gene-editing stocks and biotech ETFs.

Goldman Sachs Builds $75M Bet Across CAPR, SLS And IBRX As Major Catalysts Loom 

Goldman increased its stake in Sellas by 5.2% to 585,035 shares, worth $8.64 million.

SLS And IBRX Eye Green Weekly Close: Vanguard’s Major Stakes In Cancer Drugmakers Steal The Spotlight 

Vanguard held SLS and IBRX positions worth a combined $259 million at quarter-end.

ImmunityBio Appoints Dr. Jim Yong Kim, Former World Bank President and Global Health Leader, as Vice Chairman

ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced that Dr. Jim Yong Kim has joined the company as Vice Chairman. Dr. Kim will serve in a newly created Office of the Executive Chairman, where he will focus on strengthening the company's international and...

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

Neutral Sentiment

$SLS

$ONDS

$IBRX

$PYPL

Which of these trending stocks are you most bullish on right now - $SLS, $ONDS, $IBRX, or $PYPL?

Stocktwits

SELLAS Life Sciences Group Inc

Ondas Inc

PayPal Holdings Inc

Which of these trending stocks are you most bullish on right now - 

Stocktwits Polls

Traders are intensely focused on potential global approvals and the massive clinical upside of ANKTIVA for immune-restoration therapy.

Long-term investors believe the stock is a severely undervalued, coiled spring awaiting a short-squeeze ignition from incoming revenue news.

Market attention is shifting toward the UAE and Saudi Arabia as crucial markets for clinical trials and potential early commercial success.

Investors express significant dissatisfaction with perceived regulatory gridlock and wait for breakthroughs to bypass domestic inaction.

Feed

News

Sentiment

Earnings

Fundamentals

Info

IBRX ImmunityBio Inc

Fundamentals

Latest IBRX News